EHC - European Haemophilia Consortium / LinkedIn
Dec 16, 2025, 00:32
New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
European Haemophilia Consortium shared a post on LinkedIn:
“From fresh-frozen plasma in the 1950s to today’s extended and ultra-long half-life productsโthe evolution of replacement factor treatments for bleeding disorders showcases over 70 years of remarkable innovation and ingenuity, culminating in personalised therapy.
Want to dive deeper? Explore these new topics on the EHCucate webpage:
- History of Replacement Factor Therapies (RFT)
- Principles of Factor Replacement
- Practical Foundations of RFT
Learn more”
Follow the latest in Hemostasis Today.
-
May 25, 2026, 14:04Sophia Delicou: We Aim to Bridge Laboratory Insights and Clinical Practice for Unstable Hemoglobin Variants
-
May 25, 2026, 13:49Chaitanya Harita: Presenting AML Research at the British Society for Haematology Annual Scientific Meeting 2026
-
May 25, 2026, 13:04Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease
-
May 25, 2026, 13:04Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism
-
May 25, 2026, 13:04Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
-
May 25, 2026, 12:33Laird Bruce de Graaf: The Most Compassionate Gift You Can Give
-
May 25, 2026, 12:30Dheri Lubis: Deeper Into Immunohematology Beyond Basic Blood Grouping
-
May 25, 2026, 11:20Abdul Mannan: Why Thalassaemia Is More Than Low Haemoglobin
-
May 25, 2026, 11:06Roberta Gualtierotti: Iron Is More Than a Hematologic Parameter